Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

NCT06560801 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Dapagliflozin 10mg Tab

Sponsor

University of Erlangen-Nürnberg Medical School